1-8 of 8
Daniele Giovanni Mattei
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase Ib/II Study (NCT02488408 / BGBC003) of Bemcentinib Monotherapy or in Combination with Cytarabine or Decitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS): FINAL Results

Sonja Loges, Michael Heuser, Jolanta Chromik, Grerk Sutamtewagul, Silke Kapp-Schwoerer, Monica Crugnola, Nicola Di Renzo, Roberto Massimo Lemoli, Daniele Giovanni Mattei, Isabel Ben Batalla, Jonas Waizenegger, Melanie Janning, Lisa-Marie Rieckmann, Charles Imbusch, Niklas Beumer, David Micklam, Claudia Gorcea-Carson, Cristina Oliva, Walter Fiedler, Yesid Alvarado-Valero, Nigel McCracken, Bjorn T. Gjertsen
Journal: Blood
Blood (2023) 142 (Supplement 1): 4287.
https://doi.org/10.1182/blood-2023-181833
Published: 2023
Journal Articles

Gimema ALL2418: Interim Analysis of a Phase Iia Study of Feasibility and Effectiveness of Inotuzumab Ozogamicin in Adult Patients with B-Cell Acute Lymphoblastic Leukemia with Positive Minimal Residual Disease before Any Hematopoietic Stem Cell Transplantation

Giovanni Marconi, Alfonso Piciocchi, Sabina Chiaretti, Cristina Papayannidis, Monia Lunghi, Prassede Salutari, Patrizia Zappasodi, Alessandro Rambaldi, Attilio Olivieri, Maurizio Cavallari, Stefano Soddu, Nicola S Fracchiolla, Federica Gigli, Chiara Cattaneo, Daniele Giovanni Mattei, Anna Candoni, Giovanni Grillo, Maria Chiara Abbenante, Ernesta Audisio, Massimiliano Bonifacio, Albana Lico, Roberto Massimo Lemoli, Paolo De Fabritiis, Felicetto Ferrara, Martina Rachele Marino, Monica Messina, Anna Ferrari, Valentina Robustelli, Jacopo Nanni, Irene Della Starza, Giorgia Simonetti, Maria Stefania De Propris, Maria Teresa Bochicchio, Marco Vignetti, Paola Fazi, Giovanni Martinelli
Journal: Blood
Blood (2022) 140 (Supplement 1): 6119–6121.
https://doi.org/10.1182/blood-2022-157937
Published: 2022
Journal Articles

INO-CD22: A Multi-Center, Real-Life Study on Inotuzumab-Ozogamicin Safety and Effectiveness in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia

Cristina Papayannidis, Patrizia Zappasodi, Nicola S Fracchiolla, Francesco Di Raimondo, Daniele Giovanni Mattei, Francesco Lanza, Endri Mauro, Maria Ilaria Del Principe, Erika Borlenghi, Monica Fumagalli, Elisabetta Todisco, Simona Sica, Nicola Di Renzo, Paolo De Fabritiis, Paolo Corradini, Daniele Vallisa, Fara Petruzziello, Mario Luppi, Fabrizio Pane, Felicetto Ferrara, Francesco Passamonti, Antonino Mulè, Chiara Zingaretti, Giovanni Marconi, Irene Valli, Elisabetta Petracci, Alberto Clemente, Giuseppe Nicola Saglio, Fabio Ciceri, Giovanni Martinelli
Journal: Blood
Blood (2021) 138 (Supplement 1): 4391.
https://doi.org/10.1182/blood-2021-149157
Published: 2021
Journal Articles

Bemcentinib (Oral AXL Inhibitor) in Combination with Low-Dose Cytarabine Is Well Tolerated and Efficacious in Older Relapsed AML Patients.Updates from the Ongoing Phase II Trial (NCT02488408) and Preliminary Translational Results Indicating Bemcentinib Elicits Anti-AML Immune Responses

Sonja Loges, Grerk Sutamtewagul, Michael Heuser, Jörg Chromik, Silke Kapp-Schwoerer, Monica Crugnola, Nicola Di Renzo, Roberto M. Lemoli, Daniele Giovanni Mattei, Isabel Ben Batalla, Monica Hellesøy, Jonas Waizenegger, Melanie Janning, Charles D. Imbusch, Niklas Beumer, Austin Rayford, Jaya Nautiyal, Tzivia Berkman-Gottlieb, David Micklem, Hani Gabra, Claudia Gorcea-Carson, James B. Lorens, Walter Fiedler, Yesid Alvarado, Bjorn T. Gjertsen, Lisa-Marie Rieckmann
Journal: Blood
Blood (2021) 138 (Supplement 1): 3410.
https://doi.org/10.1182/blood-2021-147225
Published: 2021
Journal Articles

The Combination of AXL Inhibitor Bemcentinib and Low Dose Cytarabine Is Well Tolerated and Efficacious in Elderly Relapsed AML Patients: Update from the Ongoing BGBC003 Phase II Trial (NCT02488408)

Sonja Loges, MD PhD, Michael Heuser, Jörg Chromik, MD, Carlos Enrique Vigil, MD, Peter Paschka, MD, Francesca Re, MD, Nicola Di Renzo, MD, Roberto M. Lemoli, Daniele Giovanni Mattei, MD, Isabel Ben-Batalla, PhD, Monica Hellesoy, PhD, Katherine Lorens, MD, Joseph Birkett, PhD, Stuart McPherson, BSc, Jaya Nautiyal, PhD, David Micklem, PhD, Hani Gabra, MD PhD FRCPE, FRCP, James B. Lorens, PhD, Walter Fiedler, MD, Yesid Alvarado, MD, Bjorn T. Gjertsen, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 14.
https://doi.org/10.1182/blood-2020-136566
Published: 2020
Journal Articles

Durable Responses Observed in Elderly AML Patients Unfit for Intensive Chemotherapy with First-in Class Selective AXL Inhibitor Bemcentinib (BGB324) in Combination with LDAC: Phase II Open-Label Study

Sonja Loges, MD, PhD, Michael Heuser, MD, Jörg Chromik, MD, Carlos Enrique Vigil, MD, Peter Paschka, MD, Francesca Re, Nicola Di Renzo, MD, Roberto Massimo Lemoli, MD, Daniele Giovanni Mattei, MD, Isabel Ben Batalla, PhD, Monica Hellesoy, PhD, David Micklem, PhD, Robert J. Holt, PhD, James B. Lorens, PhD, Muhammad Shoaib, MD, Hassan Aly, MD PhD, Wouter Hanekom, MD, Walter Fiedler, MD, Jorge E. Cortes, MD, Bjorn T. Gjertsen, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3943.
https://doi.org/10.1182/blood-2019-128683
Published: 2019
Journal Articles

Identification of a Chromatin-Splicing Mutational Signature to Define Secondary Acute Myeloid Leukemia: A Report from the Northern Italy Leukemia Group (NILG) Prospective Trial 02/06

Chiara Caprioli, MD, Federico Lussana, MD, Silvia Salmoiraghi, BioSc, Roberta Cavagna, BioSc, Ksenija Buklijas, BioSc, Lara Elidi, BioSc, Pamela Zanghì, BioSc, Anna Michelato, PhD, Federica Delaini, MSc, Elena Oldani, MSc, Dario Ferrero, MD, Ernesta Audisio, MD, Filippo Marmont, MD, Elisabetta Terruzzi, MD, Lorella De Paoli, MD, Chiara Cattaneo, MD, Erika Borlenghi, MD, Irene Cavattoni, MD, Monica Tajana, MD, Anna Maria Scattolin, MD, Daniele Giovanni Mattei, MD, Paolo Corradini, Leonardo Campiotti, MD, Fabio Ciceri, MD, Massimo Bernardi, MD, Elisabetta Todisco, MD PhD, Agostino Cortelezzi, MD, Sergio Cortelazzo, MD, Giacomo Gianfaldoni, MD, Alberto Bosi, MD, Brunangelo Falini, MD PhD, Tamara Intermesoli, MD, Chiara Pavoni, Statistician, Renato Bassan, MD, Orietta Spinelli, PhD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1443.
https://doi.org/10.1182/blood-2019-124497
Published: 2019
Journal Articles

Clinical Impact of an Accurate Genetic Characterization of Older Acute Myeloid Leukemia Patients: A Report from the Northern Italy Leukemia Group (NILG) Randomized Trial 02/06

Chiara Caprioli, MD, Tamara Intermesoli, MD, Orietta Spinelli, PhD, Silvia Salmoiraghi, MSc, Pamela Zanghì, MSc, Roberta Cavagna, MSc, Anna Michelato, PhD, Ksenija Buklijas, MSc, Federica Delaini, MSc, Elena Oldani, MSc, Giacomo Gianfaldoni, MD, Dario Ferrero, MD, Elisabetta Terruzzi, MD, Lorella De Paoli, MD, Chiara Cattaneo, MD, Erika Borlenghi, MD, Irene Cavattoni, MD, Monica Tajana, MD, Anna Maria Scattolin, MD, Daniele Giovanni Mattei, MD, Paolo Corradini, MD, Leonardo Campiotti, MD, Fabio Ciceri, MD, Massimo Bernardi, MD, Elisabetta Todisco, MD, Agostino Cortelezzi, MD, Sergio Cortelazzo, MD, Ernesta Audisio, MD, Filippo Marmont, MD, Alberto Bosi, MD, Brunangelo Falini, MD PhD, Chiara Pavoni, Statistician, Renato Bassan, MD, Alessandro Rambaldi, MD, Federico Lussana, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 434.
https://doi.org/10.1182/blood-2018-99-113869
Published: 2018